Summary

Cell Therapy CDMO Market Size, Share, and Analysis, By Type (Stem Cell and Non-Stem Cell), By Application (Commercial and Academic Research), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW
Cell Therapy CDMO Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 22.7% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 5.9 billion and is projected to reach USD 55.8 billion by the completion of 2034.
Cell Therapy CDMO stands for Contract Development and Manufacturing Organization and offers services for the development and manufacturing of cell-based therapies. These treatments use living cells to cure or stop illnesses. CDMOs provide various services such as the development of operations, producing clinical trial materials, and manufacturing for commercial purposes. In addition, they are important for transforming laboratory findings into clinical products, thus ensuring scalability, quality control, and regulatory compliance. This collaboration allows biotech and pharmaceutical firms to focus on innovation and exploration by using the production and logistics proficiency of CDMOs to accelerate the development and accessibility of advanced cell therapies.

MARKET HIGHLIGHTS
Cell Therapy CDMO Market is projected to reach USD 55.8 billion over the forecast period, due to an increase in the demand for cell-based therapies for cancer, genetic disorders, and chronic diseases. The growth in the market is attributed to the progress in biotechnology, along with high investments and a positive regulatory ecosystem. Additionally, major stakeholders are forming strategic partnerships, making acquisitions, and implementing technological developments to improve their capabilities. Moreover, several factors are driving this positive trend, such as an increase in clinical trials and the demand for GMP-compliant manufacturing solutions. Besides, the competitive atmosphere in the market includes well-known companies and upcoming market players who are working to address the demand for advanced cell therapy production services.
Cell Therapy CDMO Market Segments:

• By Type
o Stem Cell
o Non-Stem Cell
• By Application
o Commercial
o Academic Research

MARKET DYNAMICS
Growth Drivers
Advancements in Biotechnology to Drive Growth in the Cell Therapy CDMO Market
High Investment Act as a Catalyst for Market Growth
Restraint
Regulatory Challenges in the Cell Therapy CDMO Market Will Impact the Growth

Key Players
• Lonza Group
• WuXi AppTec
• Thermo Fisher Scientific
• Catalent Inc.
• Charles River Laboratories
• Samsung Biologics
• FUJIFILM Diosynth Biotechnologies
• Cobra Biologics
• BioNTech IMFS
• CCRM
• PCT
• Apceth Biopharma
• Brammer Bio
• Novartis AG
• Parexel International Corporation
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)



Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA


Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

ページTOPに戻る

Table of Contents

1.Executive Summary
1.1. Regional Market Share
1.2.Business Trends
1.3. Cell Therapy CDMO Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1.Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4.Primary Research
2.5.Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1.Market Definition
3.2.Cell Therapy CDMO Market: COVID-19 Impact
3.3. Key Segmentations
3.4.Key Developments
3.5.Allied Industry Data
4.Cell Therapy CDMO Market – Industry Insights
4.1. Industry Segmentation
4.2.COVID-19 overview of world economy
4.3.Industry Ecosystem Channel Analysis
4.4.Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1.Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4.Market Restraints
7.5. Market Trends
8.Risk Analysis
9. Market Analysis
9.1.Porter's Five Forces
9.2. PEST Analysis
9.2.1.Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10.Cell Therapy CDMO Market
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Cell Therapy CDMO Market Size & Forecast 2024A-2034F
11.1. Overview
11.2.Key Findings
11.3.Market Segmentation
11.3.1. By Type
11.3.1.1. Stem Cell
11.3.1.1.1.By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2.Non-Stem Cell
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2.Market Share (%) 2024-2034F
11.3.1.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1.Commercial
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2.Market Share (%) 2024-2034F
11.3.2.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Academic Research
11.3.2.2.1.By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
12.North America Cell Therapy CDMO Market Size & Forecast 2024A-2034F
12.1.Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1.By Type
12.3.2. By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13.Europe Cell Therapy CDMO Market Size & Forecast 2024A-2034F
13.1.Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1.By Type
13.3.2. By Application
13.4.Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14.Asia-Pacific Cell Therapy CDMO Market Size & Forecast 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3.Market Segmentation
14.3.1.By Type
14.3.2. By Application
14.4.Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4.Japan
14.4.5.Rest of APAC
15.Middle East and Africa Cell Therapy CDMO Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1.By Type
15.3.2. By Application
15.4.Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4.South Africa
15.4.5.Rest of Middle East and Africa
16. Latin America Cell Therapy CDMO Market Size & Forecast 2024A-2034F
16.1.Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1.By Type
16.3.2. By Application
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. Competitive Landscape
17.1.Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Lonza Group
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2.Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. WuXi AppTec
18.3. Thermo Fisher Scientific
18.4. Catalent Inc.
18.5. Charles River Laboratories
18.6. Samsung Biologics
18.7. FUJIFILM Diosynth Biotechnologies
18.8. Cobra Biologics
18.9. BioNTech IMFS
18.10. CCRM
18.11.PCT
18.12. Apceth Biopharma
18.13. Brammer Bio
18.14. Novartis AG
18.15. Parexel International Corporation
18.16. Other Prominent Players
19. Appendix
20.Consultant Recommendation